Telcon RF Pharmaceutical, Foreign Investors Net Buy 21,463 Shares... Stock Price Up 0.19%

Telcon RF Pharmaceutical ranked among the top searched stocks for 3 days in the past month.

As of 10:31 AM on the 22nd, Telcon RF Pharmaceutical is trading at 5,400 KRW, up 0.19% from the previous day. This represents a 22.45% increase compared to May 29. Telcon RF Pharmaceutical is known as a manufacturer of components for wireless communication equipment.

Today, foreigners have tentatively net purchased 21,463 shares. Over the past 5 days, individual investors have net purchased 654,319 shares, while foreigners and institutions have net sold 466,829 shares and 173,745 shares, respectively.

On June 18, Telcon RF Pharmaceutical was a market topic for its strong performance following the announcement of the progress of the Phase 3b clinical trial of Vibozone Opiranserin.

[Table] Net Trading Volume of Foreigners and Institutions (Unit: shares)

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.